Bliss GVS Pharma Intrinsic Value
Bliss GVS Pharma (BLISSGVS) median intrinsic value is ₹793.70 from 9 valuation models (range ₹119–₹992), vs current price ₹396.85 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Also explore BLISSGVS share price charts to track price trends across different timeframes.
BLISSGVS Valuation Methods Summary — DCF, Graham Number & P/E
Bliss GVS Pharma intrinsic value across 9 models vs current price ₹396.85 — upside/downside and value range per method. Browse BLISSGVS balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹283.36 | ₹226.69 - ₹340.03 | -28.6% | EPS: ₹12.88, Sector P/E: 22x |
| Book Value Method | asset | ₹992.12 | ₹892.91 - ₹1091.33 | +150.0% | Book Value/Share: ₹1084.55, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹793.70 | ₹714.33 - ₹873.07 | +100.0% | Revenue/Share: ₹974.55, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹793.70 | ₹714.33 - ₹873.07 | +100.0% | EBITDA: ₹224.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹992.12 | ₹793.70 - ₹1190.54 | +150.0% | CF Growth: 13.4%, Discount: 15% |
| PEG Ratio Method | growth | ₹119.06 | ₹107.15 - ₹130.97 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹199.00 | ₹179.10 - ₹218.90 | -49.9% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹793.70 | ₹714.33 - ₹873.07 | +100.0% | ROE: 12.4%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹560.63 | ₹504.57 - ₹616.69 | +41.3% | EPS: ₹12.88, BVPS: ₹1084.55 |
BLISSGVS Intrinsic Value vs Market Price — All Valuation Models
Bliss GVS Pharma fair value range ₹119–₹992 vs current market price ₹396.85 across 9 valuation models. For current market price and key ratios, visit BLISSGVS stock price BSE.
BLISSGVS Intrinsic Value Analysis — Undervalued or Overvalued?
Bliss GVS Pharma median intrinsic value ₹793.70, current price ₹396.85 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of BLISSGVS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bliss GVS Pharma (BLISSGVS) is ₹793.70 (median value). With the current market price of ₹396.85, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹119.06 to ₹992.12, indicating ₹119.06 - ₹992.12.
Is BLISSGVS undervalued or overvalued?
Based on our multi-method analysis, Bliss GVS Pharma (BLISSGVS) appears to be trading below calculated value by approximately 100.0%.
BLISSGVS Financial Health — Key Ratios vs Industry Benchmarks
Bliss GVS Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 37.84 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.4% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.72x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BLISSGVS Cash Flow Quality — Operating & Free Cash Flow
Bliss GVS Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹106 Cr | ₹69 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹103 Cr | ₹62 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹34 Cr | ₹31 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹136 Cr | ₹85 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹64 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |